Leukemia Research
Volume 27, Issue 6 , Pages 489-491 , June 2003

ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation

  • James Goldman

      Affiliations

    • Department of Pathology and Laboratory Medicine (Transfusion Medicine Unit), University of Rochester Medical Center, Box 608, 60 Elmwood Avenue, Rochester, NY 14642, USA
    • ,
  • Jane Liesveld

      Affiliations

    • Department of Medicine (Hematology–Oncology Unit), University of Rochester Medical Center, Rochester, NY 14642, USA
    • ,
  • Diane Nichols

      Affiliations

    • Department of Medicine (Hematology–Oncology Unit), University of Rochester Medical Center, Rochester, NY 14642, USA
    • ,
  • Joanna Heal

      Affiliations

    • Department of Medicine (Hematology–Oncology Unit), University of Rochester Medical Center, Rochester, NY 14642, USA
    • ,
  • Neil Blumberg

      Affiliations

    • Department of Pathology and Laboratory Medicine (Transfusion Medicine Unit), University of Rochester Medical Center, Box 608, 60 Elmwood Avenue, Rochester, NY 14642, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-585-275-9656; fax: +1-585-273-3002.

Received 27 June 2002 ,Accepted 4 October 2002.

References 

  1. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus. Med. 2001;11:325–342
  2. Buckner CD, Clift RA, Sanders JE, et al.  ABO-incompatible marrow transplants. Transplantation. 1978;89:233–238
  3. Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABO-incompatible transplants. Transplantation. 1982;33:427–429
  4. Benjamin RJ, McGurk S, Ralston MS, et al.  ABO-incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transplantation. 1999;39:179–187
  5. Benjamin RJ, McGurk S, Ralston MS, et al.  ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion. 1999;39:1273–1274
  6. Heal J, Kenmotsu N, Rowe JM, Blumberg N. A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions. Am. J. Hematol. 1994;45:189–190
  7. Kollman C, Howe CWS, Anasetti C, et al.  Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043–2051
  8. Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood. 2000;96:1150–1156
  9. Stussi G, Seebach L, Muntwyler J, et al.  Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br. J. Haematol. 2001;113:251–253

PII: S0145-2126(02)00259-X

doi: 10.1016/S0145-2126(02)00259-X

Leukemia Research
Volume 27, Issue 6 , Pages 489-491 , June 2003

Article Tools

* Image Usage & Resolution